Iu. V. Korzh

Iu. V. Korzh

Auto-generated profile, based on publicly available information

Iu. V. Korzh

Національний фармацевтичний університет Міністерства охорони здоров’я України

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2023 in Social Pharmacy in Health Care
Verified
Journal Article
Open access
AKA. A. Kotvitska
A. A. Kotvitska
Alina VolkovaAlina Volkova
Alina Volkova
IKIu. V. Korzh
Iu. V. Korzh
ISI. O. Surikova
I. O. Surikova
OOO. S. Ovakimian
O. S. Ovakimian
OSO. V. Sevriukov
O. V. Sevriukov
Aim. To study pharmaceutical awareness of the population in the rational use of medicines using innovative marketing tools. Materials and methods. The results of an electronic survey of visitors to pharmacies using questionnaires of the author’s social project “Important facts about medicines” implemented by pharmacies are presented. The data analysis was accompanied by the use of sociological survey methods, descriptive statistics, graphic analysis, grouping methods and generalization of data. Results. Based on the data generalization the existing correlation between the level of involving pharmacy visitors in the project with the interest in obtaining important facts about medicines was found. According to the number of responses provided by visitors during the project implementation, it can be argued that the most attractive was the information about the impact of medicines while driving, and half as attractive were the facts about the peculiarities of using medicines for children. It was determined that the most general important facts about medicines were well-known for the project participants; on average 53 % of respondents had a sufficient level of awareness. Thus, the highest level of awareness was determined regarding the side effects in case of simultaneous use of medicines and alcohol; increased blood pressure in case of medicines containing caffeine; strict compliance with the patient information leaflet for taking medicines. A sufficient number of project participants (44 % of the total number of pharmacy visitors who responded) indicated that they were aware of the facts about the peculiarities of using medicines for children under one year of age. The level of pharmaceutical awareness of pharmacy visitors concerning important facts about the effects of medicines on the human body while driving was the lowest; it was 33% among all pharmacy visitors who responded. For example, pharmacy visitors were not aware of what antihistamines should not be taken by drivers. Conclusions. Based on the analysis a high level of self-motivation of visitors to expand the range of important knowledge about medicines and the effectiveness of innovative marketing tools to create pharmaceutical awareness of the population in issues of the rational use of medicines has been revealed. Key words: pharmaceutical information; pharmaceutical awareness of the population; responsible self-medication; social project.

28 June 2024 in Фармацевтичний часопис
Verified
Journal Article
Open access
PDF file
AKA. A. Kotvitska
A. A. Kotvitska
Alina VolkovaAlina Volkova
Alina Volkova
IKIu. V. Korzh
Iu. V. Korzh
OSO. V. Sevriukov
O. V. Sevriukov
ANA. A. Nozdrina
A. A. Nozdrina
Мета роботи - аналіз впливу впровадження електронних рецептів на антибактеріальні лікарські засоби для системного застосування групи J01 на їх реалізацію з аптек на прикладі препаратів хлорамфеніколу. Матеріали і методи. Матеріалами дослідження стали нормативно-правові акти з питань регулювання відпуску антибактеріальних засобів, а також дані управлінського обліку аптек, що входять до всеукраїнських аптечних мереж та розташовані у містах, селищах та селах всіх регіонів України. Використано методи контент-аналізу, ретроспективного та статистичного аналізу, графічні методи та узагальнення. Результати й обговорення. Встановлено, що реалізація хлорамфеніколу у натуральному вимірі у 2022 р. була без суттєвих сезонних коливань, одночасно визначено, що у липні 2022 р., після анонсування МОЗ України про введення е-рецепту в рамках посилення контролю за обігом антибактеріальних засобів та висвітленню цієї новини у медіа, спостерігається суттєве збільшення реалізації хлорамфеніколу всіх виробників в усіх дозах. Крім того, у серпні 2022 р., після впровадження е-рецепту продажі хлорамфеніколу у натуральному виміру не тільки не зменшилися, але залишалися більшими, ніж у попередніх місяцях. Аналіз показника середнього обсягу реалізації хлорамфеніколу у натуральному виміру однією аптекою протягом 2022-2023 рр. показав, що у березні та квітні 2023 р. обсяги реалізації хлорамфеніколу однією аптекою збільшилися на 81% та 22,73 % відповідно порівняно з 2022 р. Висновки. За результатами аналізу визначено, що впровадження е-рецепту, як додаткового регулюючого механізму за обігом АБЛЗ для системного застосування, було малоефективним для препаратів хлорамфеніколу. Анонсування змін в організації рецептурного відпуску АБЛЗ для системного застосування призвело до спонтанного, клінічно необумовленого ажіотажного попиту серед населення на лікарські засоби даної групи, коли збільшується реалізація, в даному випадку хлорамфеніколу, яка не корелює з певним захворюванням, що підтверджено даними за минулі роки в той самий період.

16 July 2024 in Social Pharmacy in Health Care
Verified
Journal Article
Open access
PDF file
LTL. V. Tereschenko
L. V. Tereschenko
IKIu. V. Korzh
Iu. V. Korzh
OTO. S. Tereschenko
O. S. Tereschenko
Alina VolkovaAlina Volkova
Alina Volkova
OAO. V. Afanasenko
O. V. Afanasenko
Aim. To assess the current state of prescription dispensing of medicines and the effectiveness of introducing electronic prescriptions (EP) based on the results of a survey of pharmacists. Materials and methods. The study materials included regulatory legal acts, scientific publications, data from the State Register of Medicines of Ukraine, and the results of a sociological survey. The general scientific (analysis, generalization, synthesis), theoretical (structural, systemic analysis) and practical (sociological analysis) methods of analysis were used in the study. Results. It has been determined that in accordance with the provisions of the current regulatory legal acts, currently there is a list of OTC medicines in Ukraine. In 2023, it included 3191 medicines. And it is only 21.6 % of all medicines registered in Ukraine as of 18.11.2023. The results of the survey of 262 pharmaceutical employees of pharmacies in different regions have shown that among the main advantages of the introduction of the drug dispensing by EP, 77.5 % of respondents point out a significant reduction in the number of errors due to doctor’s unclear handwriting, 59.9 % note reliable control over dispensing of medicines. It has been determined that 231 pharmacists (89.2 % of respondents) believe that the functioning of EP will enable pharmacies to comply with the requirements of the legislation on prescription medicines. It has been found that more than half – 201 respondents (76.7 %) believe that the introduction of EP in the national healthcare system will prevent the irrational use of antibacterial drugs. The main difficulties that pharmacists most often encounter when dispensing medicines by EP have been identified, in particular technical failures (54 %), the patient’s misunderstanding of how EP works (40.5 %), and the lack of Internet access (30.5 %). It has been found that 94.7 % of pharmacists are familiar with the latest changes in the legislation on dispensing of medicines from pharmacies. Conclusions. Based on the analysis, the main directions of solving current problems related to dispensing of prescription medicines in Ukraine have been identified. It has been determined that the introduction of EP for all finished medicines will contribute to the protection of the patient’s health, the rational use of prescription medicines and reliable control over their dispensing.

28 July 2022 in Social Pharmacy in Health Care
Verified
Journal Article
Open access
PDF file
IVI. O. Vlasenko
I. O. Vlasenko
IKI. V. Kubarieva
I. V. Kubarieva
DLDavtian L. L.
Davtian L. L.
IKIu. V. Korzh
Iu. V. Korzh
Aim. To study modern aspects of determining the costs of self-monitoring of diabetes mellitus.Materials and methods. When conducting the analysis the research objects were recommendations and regulations documents regarding the provision of medical care to diabetes patients (orders of the Ministry of Health of Ukraine, domestic and international clinical guidelines, recommendations of international organizations) and information on retail prices of glucometers and test strips in pharmacies of Kyiv, Lviv, Dnipro and Kharkiv (80 pharmacies) as of 10.01.2022. In the course of the research the content analysis, methods of grouping and summarizing data, mathematical and marketing analysis methods were applied.Results. Based on the generalization of these international recommendations and legal acts on the provision of medical care to patients with diabetes mellitus, 4 scenarios were identified regarding the number of measurements for self-monitoring. It was determined that foreign manufacturers formed the main range of glucometers for diabetes self-monitoring at the retail pharmaceutical market. The need for self-monitoring of diabetes mellitus per year was determined based on qualitative and quantitative indicators, depending on the type of diabetes mellitus and approaches to pharmacotherapy, taking into accountdomestic and international recommendations. It was found that the highest costs for test strips per year were observed for self-monitoring of Type І diabetes (5,986.0-15,622.0 UAH), and insignificant for Type ІІ diabetes with diet therapy (213.2 to 556.4 UAH). In addition, the following costs of self-monitoring (glucometer + test strips) for 1 year were found: for Type І diabetes (insulin therapy) – UAH 6,318.0-15,997.0, for Type ІІ diabetes (insulin therapy) – UAH 4,821.5-12,091.5, Type ІІ diabetes (oral hypoglycemic therapy) – UAH 2,464.0-5,939.0, Type ІІ diabetes (diet therapy) – from UAH 545.2 to UAH 1,165.6.Conclusions. Based on the analysis conducted, it has been determined that in Ukraine it is appropriate to develop measures to introduce reimbursement of costs for self-monitoring devices, namely glucometers and test strips for all categories of patients. This will help to encourage patients to conduct self-monitoring and, as a result, will become a significant factor in preventing the development of diabetes complications.Key words: retail price; diabetes; costs; self-monitoring.

29 June 2022 in Farmatsevtychnyi zhurnal
Verified
Journal Article
Open access
PDF file
НОН. В. Олєйнікова
Н. В. Олєйнікова
ЮКЮ. В. Корж
Ю. В. Корж
ІСІ. О. Сурікова
І. О. Сурікова
ОАО. В. Афанасенко
О. В. Афанасенко
Epilepsy is one of the most common serious diseases of the central nervous system in the world. The effective system of pharmaceutical care for epileptic patients requires the involvement of appreciable budgetary financial resources. In order to determine the actual state of pharmaceutical care to the population, clinical and economic studies are used, the results of which allow to optimize the cost of pharmacotherapy and ensure the implementation of the constitutional rights of Ukrainian citizens to available medical and pharmaceutical care. The aim of the study was to conduct a clinical and economic analysis of pharmacotherapy of epilepsy. The object of the study was the data of 118 medical records of patients diagnosed with epilepsy, who were treating at specialized healthcare facilities. Evaluation of the degree of pharmacotherapy rationality in epileptic patients was taken using frequency, VEN, ABC analysis. The results of the investigation of patients’ medical records showed that 87 trade names of medications (76 international non-proprietary names of medications) were prescribed for epileptic patients. The total number of prescriptions is 918. The average number of prescriptions per patient is 7, which indicates polypragmasy. It was found that the leader in the number of appointments were carbamazepine – 11.11% of the total number of prescriptions and valproic acid – 3.49%. It is proved that in the structure of prescriptions for epileptic patients the part of medication with index V was 7.89%, which indicates a low degree of prescriptions compliance with healthcare standards. According to the results of the integrated ABC and VEN analysis, it was proved that among the groups A/V, A/E, A/N, the group A/V has the largest amount of expenditures – 36.38% of total cost. In general, group N accounts for 41.97% of total costs, which may indicate the irrational use of drugs in the provision of pharmaceutical care to epileptic patients. The results of clinical and economic analysis of medical records of epileptic patients allowed to identify features in the organization of pharmaceutical care, as well as to substantiate the main directions of improving pharmacotherapy of epileptic patients with limited budget funding for healthcare.

29 April 2022 in ScienceRise: Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
IKIuliia Korzh
Iuliia Korzh
NONatalia Olieinikova
Natalia Olieinikova
MBMarharyta Beketova
Marharyta Beketova
IKInna Kubarieva
Inna Kubarieva
YKYevheniia Korobova
Yevheniia Korobova
OAOlga Afanasenko
Olga Afanasenko
The aim to conduct a comparative analysis of the population's consumption of antiepileptic drugs in the retail pharmaceutical markets of developing countries, including Ukraine, Kazakhstan and Belarus in the period 2016-2020. Materials and methods. The objects of the research were the data of marketing agencies that monitor the domestic pharmaceutical market in the countries under study. In particular, the range of AED in Ukraine was determined using the market research system «Pharmstandard» of the company «Morion». Analytical-comparative, systematic, graphical, logical, mathematical-statistical research methods were used. Results. The results of the study show that the market of antiepileptic drugs in Ukraine, Kazakhstan and Belarus mainly depends on foreign manufacturers, in particular by 60 %, 92 % and 46 % respectively in 2020, and does not meet the needs of the population in accordance with WHO recommendations. It is established that in the market of Ukraine, Kazakhstan during 2016-2019 there is a general trend of increasing retail sales of antiepileptic drugs, which are not included in the WHO Basic List of Essential Medicines, both in natural and in monetary terms. The results of the analysis of retail sales of drugs in the Belarusian market in quantitative and monetary terms indicate an increase in sales of drugs for the treatment of epilepsy, which are included in the WHO Basic List of Essential Medicines. Conclusions. The presence in Ukraine of a difficult situation with the consumption of antiepileptic drugs in comparison with other countries of the reference group indicates the need to implement comprehensive programs to combat the spread of epilepsy and the introduction of models for the rational use of limited health resources